Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 69 (representing 40 labs)

Tests names and labsConditionsGenes and analytesMethods

Rapid microarray (CGH and SNP)

Allele Diagnostics
United States
247231
  • D Deletion/duplication analysis
  • H Detection of homozygosity

Neurofibromatosis type II

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Neurofibromatosis type II

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

NF2

Neurogenetics DNA Diagnostic Laboratory Massachusetts General Hospital
United States
11
  • D Deletion/duplication analysis
  • L Linkage analysis
  • S Mutation scanning of the entire coding region
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Ataxia Exome Panel

Genetic Services Laboratory University of Chicago
United States
287480
  • C Sequence analysis of the entire coding region

Meningiomatosis/ Multiple Meningioma NGS Panel

Medical Genomics Laboratory Department of Genetics UAB
United States
44
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Schwannomatosis/ Multiple Schwannomas NGS Panel

Medical Genomics Laboratory Department of Genetics UAB
United States
23
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Peripheral Nerve Sheath Tumor NGS panel

Medical Genomics Laboratory Department of Genetics UAB
United States
66
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

BrainTumorNext

Ambry Genetics
United States
7727
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CustomNext-Cancer

Ambry Genetics
United States
6867
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Schwannomatosis Panel from Biopsy Specimen (NF2, LZTR1, SMARCB1)

Medical Genomics Laboratory Department of Genetics UAB
United States
23
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Neurofibromatosis Type 2 (NF2) Next Genetration Sequencing and Deletion/Duplication Testing

Medical Genomics Laboratory Department of Genetics UAB
United States
11
  • L Linkage analysis
  • C Sequence analysis of the entire coding region

NF2. Complete sequencing

Instituto de Medicina Genomica
Spain
11
  • C Sequence analysis of the entire coding region

NF2. MLPA testing

Instituto de Medicina Genomica
Spain
11
  • D Deletion/duplication analysis

Neurofibromatosis Type 2 via the NF2 Gene

PreventionGenetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

FAMILIAL SCHWANNOMATOSI - SMARCB1/INI1 gene

Hereditary Cancer Group - Genetic Diagnostic Unit Germans Trias I Pujol Research Institute
Spain
23
  • D Deletion/duplication analysis
  • L Linkage analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

NEUROFIBROMATOSI DE TYPE 2 - NF2 gene

Hereditary Cancer Group - Genetic Diagnostic Unit Germans Trias I Pujol Research Institute
Spain
33
  • D Deletion/duplication analysis
  • L Linkage analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

VistaSeq Brain/CNS/PNS Cancer Panel

Molecular Diagnostic Laboratory LabCorp
United States
1617
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Neurofibromatosis Type 2 , Deletions-Duplications (MLPA) NF2 Gene

Reference Laboratory Genetics
Spain
11
  • D Deletion/duplication analysis

Neurofibromatosis Type 2 , Sequencing NF2 Gene

Reference Laboratory Genetics
Spain
11
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 69

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center